The collaborative research on Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomized controlled trials has been published in the journal Open. Heart British Medical Journal
